2004
Overdose deaths attributed to methadone and heroin in New York City, 1990–1998
Bryant W, Galea S, Tracy M, Piper T, Tardiff K, Vlahov D. Overdose deaths attributed to methadone and heroin in New York City, 1990–1998. Addiction 2004, 99: 846-854. PMID: 15200580, DOI: 10.1111/j.1360-0443.2004.00693.x.Peer-Reviewed Original ResearchConceptsAccidental overdose deathsOverdose deathsOverdose mortalityAccidental drug overdose deathsPrescription of methadoneTotal overdose deathsRole of methadoneDrug overdose deathsChief Medical ExaminerNew York CityMethadone treatmentMethadoneEffective interventionsHeroinDeathYork CityMedical examinersRecent reportsMortalityPeriod of studySame intervalOpiatesPeriodProportion
2002
DRUG USER TREATMENT REFERRALS AND ENTRY AMONG PARTICIPANTS OF A NEEDLE EXCHANGE PROGRAM
Riley E, Safaeian M, Strathdee S, Brooner R, Beilenson P, Vlahov D. DRUG USER TREATMENT REFERRALS AND ENTRY AMONG PARTICIPANTS OF A NEEDLE EXCHANGE PROGRAM. Substance Use & Misuse 2002, 37: 1869-1886. PMID: 12511056, DOI: 10.1081/ja-120014088.Peer-Reviewed Original ResearchConceptsNEP participantsNeedle exchange programsTreatment referralMethadone treatmentMultiple logistic regression modelUse of speedballsDrug user treatmentNeedle exchange program participantsLogistic regression modelsMedian ageMethadone maintenanceOdds ratioFemale genderFirst injectionDrug useTreatment entryReferral
2001
Time to initiating highly active antiretroviral therapy among HIV-infected injection drug users
Celentano D, Galai N, Sethi A, Shah N, Strathdee S, Vlahov D, Gallant J. Time to initiating highly active antiretroviral therapy among HIV-infected injection drug users. AIDS 2001, 15: 1707-1715. PMID: 11546947, DOI: 10.1097/00002030-200109070-00015.Peer-Reviewed Original ResearchConceptsInjection drug usersActive antiretroviral therapyAntiretroviral therapyDrug usersCell countLow health care accessNon-HAART regimensAntiretroviral therapy useDual combination therapyProportional hazards regressionMain outcome measuresMore treatment optionsHealth care accessNon-drug usersHAART regimenLow CD4HAART useHIV careCohort studyStudy clinicTherapy useSelf-reported initiationHazards regressionMethadone treatmentTreatment eligibility
2000
Consideration of a North American heroin-assisted clinical trial for the treatment of opiate-dependent individuals
Kuo I, Fischer B, Vlahov D. Consideration of a North American heroin-assisted clinical trial for the treatment of opiate-dependent individuals. International Journal Of Drug Policy 2000, 11: 357-370. PMID: 10967518, DOI: 10.1016/s0955-3959(00)00057-8.Peer-Reviewed Original ResearchMethadone treatmentMajor public health problemOpiate addictsAdditional treatment strategiesHeroin-assisted treatmentPrincipal treatment modalityPublic health problemOpiate-dependent individualsSubstance abuse treatmentTreatment modalitiesClinical trialsTreatment outcomesTreatment strategiesSide effectsEconomic burdenHealth problemsInjectable opiatesTreatment programAbuse treatmentTreatment participationEffective interventionsTreatmentPositive resultsAddictsRecent studies